Nazim Benzerdjeb

ORCID: 0000-0002-3903-9610
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Intraperitoneal and Appendiceal Malignancies
  • Appendicitis Diagnosis and Management
  • Ovarian cancer diagnosis and treatment
  • Salivary Gland Tumors Diagnosis and Treatment
  • Ear and Head Tumors
  • Head and Neck Cancer Studies
  • Occupational and environmental lung diseases
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Endometriosis Research and Treatment
  • Oral and Maxillofacial Pathology
  • Lung Cancer Treatments and Mutations
  • Cancer Genomics and Diagnostics
  • Neuroendocrine Tumor Research Advances
  • Radiomics and Machine Learning in Medical Imaging
  • Tumors and Oncological Cases
  • Pancreatic and Hepatic Oncology Research
  • Respiratory Support and Mechanisms
  • Cardiac tumors and thrombi
  • Pleural and Pulmonary Diseases
  • Multiple Myeloma Research and Treatments
  • Molecular Biology Techniques and Applications
  • Neonatal Respiratory Health Research
  • Epigenetics and DNA Methylation
  • Omental and Epiploic Conditions
  • Voice and Speech Disorders

Hôpital Lyon Sud
2019-2025

Hospices Civils de Lyon
2019-2025

Université Claude Bernard Lyon 1
2015-2025

Centre de Recherche en Cancérologie de Lyon
2021-2025

Université de Strasbourg
2024

Université de Montpellier
2024

Centre Hospitalier Universitaire de Montpellier
2024

Hôpital de la Croix-Rousse
2023

Lyon College
2023

The University of Texas MD Anderson Cancer Center
2022

Recurrent gene fusions are common in salivary gland tumors including benign tumors, such as pleomorphic adenoma (PA) and myoepithelioma (ME). In cases where chromosomal rearrangement is identified the 1 (PLAG1) gene, different partners found. Oncocytic metaplasia, characterized by oncocytes with abundant eosinophilic granular cytoplasm hyperchromatic nuclei, a well-known phenomenon neoplasms. However, pure oncocytic variant of PA/ME showed PLAG1 rearrangements involving various at molecular...

10.1097/pas.0000000000002206 article EN The American Journal of Surgical Pathology 2024-03-18

Abstract Background The incidence of gastric poorly cohesive carcinoma (PCC) is increasing. prognosis for patients with peritoneal metastases remains poor and the role cytoreductive surgery (CRS) hyperthermic intraperitoneal chemotherapy (HIPEC) controversial. aim was to clarify impact PCC treated by CRS or without HIPEC. Methods All from cancer HIPEC, in 19 French centres, between 1989 2014, were identified institutional databases. Clinicopathological characteristics outcomes compared...

10.1093/bjs/znab200 article EN British journal of surgery 2021-09-08

Oropharyngeal squamous cell carcinomas (OPSCC) related to human papillomavirus (HPV) infection have a better prognosis than those without HPV infection. Although p16INK4a overexpression is used as surrogate marker for infection, 5-20% of p16-positive OPSCC are described being unrelated with worse overall survival compared OPSCC-related HPV. There therefore risk undertreating proportion patients falsely considered be HPV-driven because p16 positivity. TP53 mutations highly prevalent in driven...

10.1111/his.14350 article EN Histopathology 2021-02-10

Aims Salivary gland neoplasms (SGN) exhibiting the HMGA2 :: WIF1 fusion are recognized by their resemblance to histology found in canalicular adenoma. Recently, ~20% of cases among 28 ‐rearranged‐SGN showed malignancy and adverse outcomes (recurrence, distant metastasis, disease‐specific mortality). Among them, MDM2/CDK4 amplifications were identified one case. This outcome suggests that could be useful predict an aggressive course carcinoma ex‐pleomorphic adenoma (CEPA). Methods Results We...

10.1111/his.15209 article EN cc-by-nc Histopathology 2024-05-06

Mesothelioma is a rare and aggressive malignant neoplasm arising from mesothelial cells, which occasionally manifests recurrent fusions. EWSR1/FUS-CREB, YY1, MAP3K8, NR4A3, ALK-rearranged proliferations have been reported in limited series with no clear histological or clinical correlations, limiting clinicians' ability to assess prognosis integrate these new entities into therapeutic decisions. The aim of this study was better characterize rearranged histologically, molecularly, clinically....

10.1016/j.esmoop.2024.103644 article EN cc-by ESMO Open 2024-07-25
Alexis Trécourt Naoual Bakrin Olivier Gléhen Witold Gertych Laurent Villeneuve and 95 more Sylvie Isaac Nazim Benzerdjeb Juliette Fontaine Catherine Genestie Peggy Dartigues Agnès Leroux F. Quénet Frédéric Marchal Cécile Odin Lakhdar Khellaf Magali Svrcek Sixte Thierry Marilyn Augros Alhadeedi Omar Mojgan Devouassoux‐Shisheboran Vahan Képénékian J. Abba Karine Abboud A Aimé Kocéila Amroun Thierry André C. Arvieux Gerlinde Averous-Lang A Bardier Houda Ben Rejeb Jean-Marc Béréder Philippe Bertheau Fréderic Bibeau Valérie Boige Pierre‐Emmanuel Bonnot Olivier Bouché Fatiha Bouhidel Marie-Dominique Bouzard Cécile Brigand Chloé Broudin Bertrand Célérier Cécilia Ceribelli Aurélie Charissoux A Chevallier Elise Clément J Coget Thomas Courvoisier-Clément Marie Dazza Cécile de Chaisemartin Frédéric Di Fiore Frédéric Dumont Sylvaine Durand‐Fontanier Clarisse Eveno Anne-Cécile Ezanno Olivier Facy Gwénaël Ferron Johann Gagnière Alexandre Galan Maximiliano Gelli Laurent Ghouti Laurence Gladieff Diane Goèré Jean‐Marc Guilloit Frédéric Guyon Bruno Heyd Marie‐Françoise Heymann Martin Hübner Claire Illac-Vauquelin Rachid Kaci Amaniel Kefleysus Vahan Képénékian Réza Kianmanesh Marie‐Hélène Laverrière Valérie Lebrun-Ly Jérémie H. Lefèvre Bernard Lelong Anne‐Isabelle Lemaistre Brice Malgras Pascale Mariani Antoine Mariani Pierre Meeus Eliane Mery-Lamarche Fabrice Narducci Stéphanie Nougaret David Orry Pablo Ortega‐Deballon Brice Paquette Julien Péron Patrice Peyrat Denis Pezet N. Pirró Marc Pocard Flora Poizat Judith Raimbourg Patrick Rat Pauline Ries Pascal Rousset Pierre‐Yves Sage Hélène Senellart Olivia Sgarbură

Abstract Background Ovarian pseudomyxoma peritonei (OPMP) are rare, without well-defined therapeutic guidelines. We aimed to evaluate cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) treat OPMP. Methods Patients from the French National Network for Rare Peritoneal Tumors (RENAPE) database with proven OPMP treated by CRS/HIPEC histologically normal appendix digestive endoscopy were retrospectively included. Clinical follow-up data collected. Histopathological...

10.1245/s10434-023-14850-0 article EN cc-by Annals of Surgical Oncology 2024-02-10

// Nazim Benzerdjeb 1, 2 , Henri Sevestre Ahmed Ahidouch 2, 3 Halima Ouadid-Ahidouch 1 Laboratory of Cellular and Molecular Physiology, LPCM: EA 4667, SFR CAP-SANTE (FED 4231), UFR Sciences, Amiens, France Department Pathology, Amiens University Hospital, Biology, Ibn Zohr University, Agadir, Morocco Correspondence to: Ouadid-Ahidouch, email: halima.ahidouch-ouadid@u-picardie.fr Benzerdjeb, nazim.benz@gmail.com Keywords: orai3, lung adenocarcinoma, prognostic marker, survival Received: June...

10.18632/oncotarget.13149 article EN Oncotarget 2016-11-07

Aims The peritoneal regression grading score (PRGS) and cytology (PC) assess response to chemotherapy in metastasis (PM) a setting of palliative treatment by pressurized intraperitoneal aerosol (PIPAC). Progression has been defined as an increase PRGS between first third PIPAC procedures (iPRGS). iPRGSand positive were not associated with prognostic impact. These results may be explained lack statistical power. Also, it is known whether the mean or highest among taken biopsies bears clinical...

10.1111/his.14092 article EN Histopathology 2020-02-15

Programmed death-ligand 1 (PD-L1) is the most validated predictive biomarker used for treatment of head and neck squamous cell carcinoma (HNSCC) with immune checkpoint inhibitors (ICI). Several gene expression-based signatures surrogate activation IFN-gamma pathway presence tertiary lymphoid structures (TLS) have also been proposed as potential biomarkers. While they may a therapeutic implication, longitudinal changes either PD-L1 or expression profiles between initial recurrent HNSCC...

10.1016/j.oraloncology.2021.105368 article EN cc-by-nc-nd Oral Oncology 2021-06-07

Non‐small cell lung cancer (NSCLC) affects 10–50% of patients with epidermal growth factor receptor ( EGFR ) mutations. Osimertinib is a third‐generation tyrosine kinase inhibitor (TKI) that radically changes the outcome tumors bearing sensitizing or T790M resistance However, usually occurs, and new therapeutic combinations need to be explored. The chorioallantoic membrane (CAM) xenograft model ideal for studying aggressive tumor responses complex due its vascularization microenvironment....

10.1002/2211-5463.13970 article EN cc-by FEBS Open Bio 2025-01-30

High-grade appendiceal mucinous neoplasm (HAMN) is used to describe a rare epithelial of the appendix characterized by pushing-type invasion and high-grade cytologic atypia. Its implications regarding lymph node spread necessity right colectomy are currently debate. The objective present study was assess clinicopathologic characteristics, risk peritoneal metastasis, long-term outcomes patients diagnosed as HAMN in comparison low-grade (LAMN) adenocarcinoma, treated hemicolectomy. A total 443...

10.1097/pas.0000000000002373 article EN cc-by-nc-nd The American Journal of Surgical Pathology 2025-02-20

<title>Abstract</title> Peritoneal mesothelioma (PM) is a rare aggressive cancer with limited treatment options upon progression. Genomic profiling European (Arcagen cohort) and French (AURAGEN initiatives aim to guide treatments for cancers. This study presents the initial findings from these efforts. Molecular analysis (n = 56, 55.4% females, mean 55.9 years) showed high success rate identify clinically relevant mutations; majority of patients harbored <italic>BAP1</italic>,...

10.21203/rs.3.rs-5699044/v1 preprint EN cc-by Research Square (Research Square) 2025-03-31

Objective Structured Clinical Examinations (OSCE) are an essential component of the reform second cycle medical studies in France, aiming to reliably and objectively assess students' clinical skills. We propose tools develop scenarios adapted pathology, allowing evaluation ability interpret histopathological reports, integrate these results into management, communicate pathology findings clearly understandably patients. The article also presents a practical application OSCE hospital setting:...

10.1016/j.annpat.2025.04.010 article EN cc-by Annales de Pathologie 2025-05-01

Background To investigate the effect of intraductal carcinoma prostate (IDC‐P) in radical prostatectomy (RP) specimens context site recurrence, time to and cancer‐specific survival two academic cohorts locally, regionally, or distantly recurrent cancer. Methods Our cohort included men enrolled into tissue repositories from 1993 2011, who were treated with first‐line RP later experienced local regional distant metastasis (together termed clinical CR). material was reviewed identify IDC‐P...

10.1002/pros.23513 article EN The Prostate 2018-03-30

Prostate cancer (PC) is the most frequently diagnosed in North American men. Pathologists are critical need of accurate biomarkers to characterize PC, particularly confirm presence intraductal carcinoma prostate (IDC-P), an aggressive histopathological variant for which therapeutic options now available. Our aim was identify IDC-P with Raman micro-spectroscopy (RμS) and machine learning technology following a protocol suitable routine clinical histopathology laboratories.

10.1371/journal.pmed.1003281 article EN cc-by PLoS Medicine 2020-08-14

Abstract Aim The peritoneal cancer index (PCI) is one of the strongest prognostic factors in patients undergoing cytoreductive surgery (CRS) for colorectal metastases. Using pathological evaluation, however, disease extent differs a large proportion patients. Our aim was to study correlation between radiological (rPCI), surgical (sPCI) and (pPCI) PCI order determine affecting discordance these indices their potential therapeutic implications. Method From July 2018 December 2019, 128 were...

10.1111/codi.15368 article EN Colorectal Disease 2020-09-17

The liquid-based cytology Papanicolaou (Pap) test has gradually replaced the conventional Pap test, as it seems to be more efficient, in part because uses computer assistance. However, diagnoses are still subjective and cost-consuming or time-consuming. authors describe a new digital holographic microscopy instrument accompanying software. This technology provides an instantaneous, 3-dimensional image reconstruction of cells directly from uterine cervical sample vial.Analyses were performed...

10.1002/cncy.21727 article EN Cancer Cytopathology 2016-05-02
Coming Soon ...